CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Research works printed but not linked: 3
- 47. Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y, Mol. Cell (2018), doi:10.1016/j.molcel. 2018.01.025. · doi:10.1016/j.molcel
- 63. Chen JS, Ma E, Harrington LB, Tian X, Doudna JA, bioRxiv, 226993 (2017).
- 71. Charlesworth CT et al., bioRxiv, 243345 (2018).
Cited by
Items 301–400 of 1,000
Challenges and Advances in Genome Editing Technologies in Streptomyces
Zhao, Y., Li, G., Chen, Y., & Lü, Y. (2020) · Biomolecules · doi:10.3390/biom10050734 · Cited by 54
“Unlike Cre and I-SceI nuclease-based genome editing, CRISPR/Cas-based technology does not require the pre-integration of a unique enzyme recognition sequence into the genome, but employs a transcribed synthetic guide RNA (sgRNA, the chimera of crRNA and tracrRNA), or only crRNA, to direct Cas proteins to any site on t…”
BackgroundCBRPP: a new RNA-centric method to study RNA–protein interactions
Li, Y., Liu, S., Cao, L., Luo, Y., Du, H., Li, S., Zhang, Z., Guo, X., Tian, W., Wong, C. C. L., et al. (2021) · RNA Biology · doi:10.1080/15476286.2021.1873620 · Cited by 56
“The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-associated proteins (Cas) system has revolutionized modern molecular biology [50].”
BackgroundNoncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications
Shahzad, U., Krumholtz, S. L., Rutka, J. T., & Das, S. (2021) · Cancers · doi:10.3390/cancers13071555 · Cited by 51
Son, H., Park, J., Hwang, I., Jung, Y., Bae, S., & Lee, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113747118 · Cited by 49
Zou, R. S., Marín-González, A., Liu, Y., Liu, H. B., Shen, L. L., Dveirin, R. K., Luo, J. X. J., Kalhor, R., & Ha, T. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00975-z · Cited by 49
Rojas, A. A. R., Swidah, R., & Schindler, D. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.982975 · Cited by 50
“Today, the organism of choice to tackle a challenge no longer needs to be haploid; CRISPR-based engineering allows efficient engineering of diploid and polyploid organisms (Knott and Doudna, 2018; Lian et al., 2018).”
BackgroundCRISPR-Cas technology in modifying food crops.
Islam, T. (2019) · CABI Reviews · doi:10.1079/pavsnnr201914050 · Cited by 62
Efficient One-Step Knockout by Electroporation of Ribonucleoproteins Into Zona-Intact Bovine Embryos
Camargo, L. S. A., Owen, J. R., Eenennaam, A. L. V., & Ross, P. J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.570069 · Cited by 51
“Gene editing technologies can find applications ranging from basic research to gene therapy (Doudna and Charpentier, 2014; Knott and Doudna, 2018).”
BackgroundPROTACs and Building Blocks: The 2D Chemical Space in Very Early Drug Discovery
Ermondi, G., Jiménez, D. G., & Caron, G. (2021) · Molecules · doi:10.3390/molecules26030672 · Cited by 50
“Notably, they have been often related to protein dependent diseases, whose main treatment scopes act at the transcriptional (CRISPR/Cas9) or the post-translational level [3,4].”
BackgroundGupta, E., Saxena, J., Kumar, S., Sharma, U., Rastogi, S., Srivastava, V. K., Kaushik, S., & Jyoti, A. (2023) · Diagnostics · doi:10.3390/diagnostics13020277 · Cited by 50
“Genomic loci can be precisely identified, altered, modified, regulated and tagged in a variety of cells and organisms [151,152].”
BackgroundEfficient base editing with high precision in rabbits using YFE-BE4max
Liu, Z., Chen, S., Shan, H., Jia, Y., Chen, M., Song, Y., Lai, L., & Li, Z. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2244-3 · Cited by 49
Time for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease
Joseph, S. A., Taglialatela, A., Leuzzi, G., Huang, J., Cuella-Martin, R., & Ciccia, A. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102943 · Cited by 48
“The development of CRISPR-based technologies [276] has produced an expansive toolbox of genome editing reagents to define genetic interactions.”
BackgroundHighly Sensitive Immuno-CRISPR Assay for CXCL9 Detection
Lee, I., Kwon, S., Sorci, M., Heeger, P. S., & Dordick, J. S. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03705 · Cited by 47
Highly efficient base editing with expanded targeting scope using SpCas9‐NG in rabbits
Liu, Z., Shan, H., Chen, S., Chen, M., Song, Y., Lai, L., & Li, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901587r · Cited by 47
HEPN RNases – an emerging class of functionally distinct RNA processing and degradation enzymes
Pillon, M. C., Gordon, J., Frazier, M. N., & Stanley, R. E. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1856769 · Cited by 46
“CRISPR-Cas systems provide microbial organisms with adaptive immunity against foreign genetic elements, such as RNA transcripts generated from phage genomic DNA, through a multi-step process of adaptation, expression, and interference (Knott and Doudna, 2018).”
BackgroundA naturally DNase-free CRISPR-Cas12c enzyme silences gene expression
Huang, C. J., Adler, B. A., & Doudna, J. A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.020 · Cited by 48
Self-citationSun, X. H., Hua, W., Wang, K., Song, J., Zhu, B., Gao, X., & Liang, P. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123389 · Cited by 39
Sahu, A., Verma, R., Gupta, U., Kashyap, S., & Sanyal, I. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00722-1 · Cited by 53
“The two-component machinery, gRNA and Cas (endonuclease) "programmable" direct complementary base pairing with target DNA adjacent to PAM (trinucleotide usually NGG), a protospacer adjacent motif that is essential for target recognition [36].”
Kang, Y., Wang, J., Zhang, W., Xu, Y., Xu, B., Qu, G., Yu, Y., Yan, B., & Su, G. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131487 · Cited by 46
“Clustered, regularly interspaced short palindromic repeats and CRISPR-associated protein (CRISPR-Cas) system is an adaptive immune defense system of prokaryotes against viral invasion and represents the most popular genome editing tool [20-22].”
BackgroundPolyplex designs for improving the stability and safety of RNA therapeutics
Uchida, S., Lau, C. Y. J., Oba, M., & Miyata, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114972 · Cited by 52
Next-generation CRISPR-based diagnostic tools for human diseases
Wang, T., Wang, Z., Bai, L., Zhang, X., Feng, J., Qian, C., Wang, Y., & Wang, R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117328 · Cited by 50
Hydrolytic endonucleolytic ribozyme (HYER) is programmable for sequence-specific DNA cleavage
Liu, Z.-X., Zhang, S., Zhu, H.-Z., Chen, Z.-H., Yang, Y., Li, L.-Q., Lei, Y., Liu, Y., Li, D., Sun, A., et al. (2024) · Science · doi:10.1126/science.adh4859 · Cited by 49
Sun, K. W., Pu, L., Chen, C., Chen, M., Li, K., Li, X., Li, H., & Geng, J. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae176 · Cited by 52
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
Raaijmakers, R. H. L., Ripken, L., Ausems, C. R. M., & Wansink, D. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153689 · Cited by 47
“Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system (Cas) methodology has a huge impact on research and gene therapy development by its ability to accurately target a specific locus in the genome of eukaryotes [1].”
BackgroundTargeted mutagenesis in Arabidopsis thaliana using CRISPR‐Cas12b/C2c1
Wu, F. H., Qiao, X., Zhao, Y., Zhang, Z., Gao, Y., Shi, L., Du, H., Wang, L., Zhang, Y., Zhang, Y., et al. (2020) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12944 · Cited by 48
Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3
Yoshimi, K., Takeshita, K., Kodera, N., Shibumura, S., Yamauchi, Y., Omatsu, M., Umeda, K., Kunihiro, Y., Yamamoto, M., & Mashimo, T. (2022) · Nature Communications · doi:10.1038/s41467-022-32618-0 · Cited by 46
Digital CRISPR systems for the next generation of nucleic acid quantification
Politza, A. J., Nouri, R., & Guan, W. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.116917 · Cited by 46
“Overall, Cas9 remains a popular tool for gene editing despite its design complexities.”
BackgroundMethodInfluentialCas3 Protein—A Review of a Multi-Tasking Machine
He, L., James, M. S. J., Radovčić, M., Ivančić-Baće, I., & Bolt, E. L. (2020) · Genes · doi:10.3390/genes11020208 · Cited by 51
Hu, D., Yu, Y., Wang, C., Long, Y., Liu, Y., Li, F., Lu, D., Liu, B., Jia, J., Xia, R., et al. (2021) · The Plant Cell · doi:10.1093/plcell/koab162 · Cited by 53
Yan, C., Shi, G., & Chen, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c04548 · Cited by 44
A Cas3-base editing tool for targetable in vivo mutagenesis
Zimmermann, A., Prieto-Vivas, J. E., Cautereels, C., Gorkovskiy, A., Steensels, J., de Peer, Y. V., & Verstrepen, K. J. (2023) · Nature Communications · doi:10.1038/s41467-023-39087-z · Cited by 49
Wang, B., Xu, Y., Zhang, T., Wang, H., Zhang, X., Wu, Z., Zhao, W., Chen, H., & Xu, J. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c03723 · Cited by 44
CRISPR-microfluidics nexus: Advancing biomedical applications for understanding and detection
Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Chen, P. (2024) · Sensors and Actuators A: Physical · doi:10.1016/j.sna.2024.115625 · Cited by 42
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
Zhang, F., Song, G., & Tian, Y. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12069 · Cited by 48
Okafor, I. C., Singh, D., Wang, Y., Jung, M., Wang, H., Mallon, J. P., Bailey, S., Lee, J. K., & Ha, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1058 · Cited by 53
Wang, Y., Bao, Y., Zhang, S., & Wang, Z. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1605-0 · Cited by 47
“spaced short palindromic repeats (CRISPR)-associated (Cas) systems can be used to manipulate splicing (Figure 4) (Knott and Doudna, 2018; Pickar-Oliver and Gersbach, 2019).”
BackgroundCRISPR screen in mechanism and target discovery for cancer immunotherapy
Liu, D., Zhao, X., Tang, A., Xu, X., Liu, S., Zha, L., Ma, W., Zheng, J., & Shi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188378 · Cited by 48
Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1
Zhang, B., Luo, D., Li, Y., Perčulija, V., Chen, J., Lin, J., Ye, Y., & Ouyang, S. (2021) · Nature Communications · doi:10.1038/s41467-021-23876-5 · Cited by 47
Pattharaprachayakul, N., Lee, M., Incharoensakdi, A., & Woo, H. M. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2020.109619 · Cited by 43
GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
Zuo, E., Sun, Y., Wu, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0361-1 · Cited by 46
Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide
Liu, Z., Chen, S., Jia, Y., Shan, H., Chen, M., Song, Y., Lai, L., & Li, Z. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1775-2 · Cited by 35
Micro-Electromechanical Systems-based Sensors and Their Applications
Nazir, S., & Kwon, O. S. (2022) · Applied Science and Convergence Technology · doi:10.5757/asct.2022.31.2.40 · Cited by 43
Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease
Zhu, L., Liu, K. Y., Feng, Q., & Liao, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10385-1 · Cited by 44
Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
Cheng, R., Wang, S., & Santos, H. A. (2023) · Biomedical Technology · doi:10.1016/j.bmt.2023.01.001 · Cited by 43
Unveiling the RNA-mediated allosteric activation discloses functional hotspots in CRISPR-Cas13a
Sinha, S., Vargas, A. M. M., Arantes, P. R., Patel, A. C., O’Connell, M. R., & Palermo, G. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1127 · Cited by 44
“The transformative use of CRISPR-Cas9 for genome editing ( 2 ) led to the ‘boom’ of the ‘CRISPR field’ and the discovery of novel CRISPR-Cas systems that remarkably expand applications in genome editing and beyond ( 3–5 ).”
RNA nanotechnology in synthetic biology
Kim, J., & Franco, E. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.016 · Cited by 45
Allele-specific genome targeting in the development of precision medicine
Wu, J., Tang, B., & Tang, Y. (2020) · Theranostics · doi:10.7150/thno.43298 · Cited by 45
“Since the expanded engineered Cas variants or expanded tool of the CRISPR system, as well as their respective applications have been recently comprehensively reviewed elsewhere (please refer to [77-84]), we are not going to describe them in much more details in this review.”
BackgroundWang, A. S., Chen, L. C., Wu, R. A., Hao, Y., McSwiggen, D. T., Heckert, A. B., Richardson, C. D., Gowen, B. G., Kazane, K. R., Vu, J. T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.014 · Cited by 49
“Cas9-BirA* and dCas9-BirA* programmed with the on-target gRNA had nearly identical interactors (Supplemental Figure 2A), consistent with prior in vitro data indicating that Cas9 obscures a DSB so that repair factors are not preferentially enriched around Cas9 (Clarke et al., 2018; Richardson et al., 2016b).”
BackgroundInfluentialCRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics
Lu, J., Liu, J., Guo, Y., Zhang, Y., Xu, Y., & Wang, X. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.007 · Cited by 46
Zhou, P., Liu, W., Cheng, Y., & Qian, D. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1718 · Cited by 50
“However, the critical elements need to be considered are that CRISPR–Cas9 may bring about insecure results such as chromosome abnormalities and nontarget genome cleavages in human (Knott & Doudna, 2018; Wang, Zhang, et al., 2020).”
BackgroundMethodCharacterization of Cme and Yme thermostable Cas12a orthologs
Fuchs, R. T., Curcuru, J. L., Mabuchi, M. Y., Noireterre, A., Weigele, P., Sun, Z., & Robb, G. B. (2022) · Communications Biology · doi:10.1038/s42003-022-03275-2 · Cited by 42
Song, N., Chu, Y., Li, S., Dong, Y., Fan, X., Tang, J., Guo, Y., Teng, G., Yao, C., & Yang, D. (2023) · Science Advances · doi:10.1126/sciadv.adi3602 · Cited by 42
DNA on the move: mechanisms, functions and applications of transposable elements
Schmitz, M., & Querques, I. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13743 · Cited by 43
“1C) [40,41].”
CRISPR-Directed Microbiome Manipulation across the Food Supply Chain
Barrangou, R., & Notebaart, R. A. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.03.006 · Cited by 41
RNA-guided piggyBac transposition in human cells
Hew, B. E., Sato, R., Mauro, D., Stoytchev, I., & Owens, J. B. (2019) · Synthetic Biology · doi:10.1093/synbio/ysz018 · Cited by 45
Multiple Origins and Specific Evolution of CRISPR/Cas9 Systems in Minimal Bacteria (Mollicutes)
Ipoutcha, T., Τsarmpopoulos, Ι., Talenton, V., Gaspin, C., Moisan, A., Walker, C. A., Brownlie, J., Blanchard, A., Thébault, P., & Sirand‐Pugnet, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02701 · Cited by 54
A Defect in Thymic Tolerance Causes T Cell–Mediated Autoimmunity in a Murine Model of COPA Syndrome
Deng, Z., Law, C. S., Ho, F. O., Wang, K. M., Jones, K. D., Shin, J., & Shum, A. K. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000028 · Cited by 41
“used to correct a COPA mutation in the thymus (45).”
MethodJarak, I., Pereira‐Silva, M., Paiva‐Santos, A. C., Veiga, F., Cabral, H., & Figueiras, A. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101217 · Cited by 44
Janghorban, M., Aradanas, I., Kazemi, S., Ngaju, P., & Pandey, R. (2022) · Biosensors · doi:10.3390/bios12110986 · Cited by 43
“Cas enzymes, upon binding to these crRNAs, form a complex which can search for and cleave target sequences complementary to the crRNAs (Figure 3c) [96].”
BackgroundUnlocking Genome Editing: Advances and Obstacles in CRISPR/Cas Delivery Technologies
Kaupbayeva, B., Tsoy, A., Safarova, Y., Nurmagambetova, A., Murata, H., Matyjaszewski, K. A., & Askarova, S. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15110324 · Cited by 46
Liu, Z., Zhang, Y., & Nielsen, J. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01236 · Cited by 41
CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci
Chylinski, K., Hubmann, M., Hanna, R. E., Yanchus, C., Michlits, G., Uijttewaal, E. C. H., Doench, J. G., Schramek, D., & Elling, U. (2019) · Nature Communications · doi:10.1038/s41467-019-13403-y · Cited by 43
Metabolomics should be deployed in the identification and characterization of gene‐edited crops
Fraser, P. D., Aharoni, A., Hall, R. D., Huang, S., Giovannoni, J. J., Sonnewald, U., & Fernie, A. R. (2020) · The Plant Journal · doi:10.1111/tpj.14679 · Cited by 40
An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression
Duke, C. G., Bach, S. V., Revanna, J. S., Sultan, F. A., Southern, N. T., Davis, M. N., Carullo, N. V. N., Bauman, A. J., Phillips, R. A., & Day, J. J. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.00009 · Cited by 47
“Advances in CRISPR/Cas9 technology have revolutionized functional investigations of gene expression (Heidenreich and Zhang, 2016; Huang et al., 2018; Knott and Doudna, 2018; Zhang, 2019).”
BackgroundRecent progress in CRISPR/Cas9-based genome editing for enhancing plant disease resistance
Boubakri, H. (2023) · Gene · doi:10.1016/j.gene.2023.147334 · Cited by 43
He, C., Ali, D. J., Qi, Y., Li, Y., Sun, B., Liu, R., Sun, B., & Xiao, Z. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01902-6 · Cited by 40
Xi, Z., Vats, A., Sahel, J., Chen, Y., & Byrne, L. C. (2022) · Nature Communications · doi:10.1038/s41467-022-35361-8 · Cited by 44
Yang, P., Lou, Y., Geng, Z., Guo, Z., Wu, S., Li, Y., Song, K., Shi, T., Zhang, S., Xiong, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067890 · Cited by 41
“…Myh6 RNAs and prevents cardiac hypertrophy without apparent adverse effects, demonstrating it is a safe and effective approach for treating genetic disorders. repeats and their associated protein 13) has been identified recently as a valuable programmable sequence-specific RNA endonuclease.”
BackgroundCRISPR-Cas immunity, DNA repair and genome stability
Cubbon, A., Ivančić-Baće, I., & Bolt, E. L. (2018) · Bioscience Reports · doi:10.1042/bsr20180457 · Cited by 44
Subtype-specific cardiomyocytes for precision medicine: Where are we now?
Zhao, M., Shao, N., & Garg, V. (2020) · Stem Cells · doi:10.1002/stem.3178 · Cited by 40
Biswas, P., Anand, U., Ghorai, M., Pandey, D. K., Jha, N. K., Behl, T., Kumar, M., CHAUHAN, R., Shekhawat, M. S., & Dey, A. (2021) · Biotechnology Journal · doi:10.1002/biot.202100507 · Cited by 42
Liu, S., Wang, C., Wang, Z., Xiang, K., Zhang, Y., Fan, G., Zhao, L., Han, H., & Wang, W. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114078 · Cited by 39
Detection Methods for Foodborne Viruses: Current State-of-Art and Future Perspectives
Yin, L., Li, Y., Zhang, W., Han, X., Wu, Q., Xie, Y., Fan, J., & Ma, L. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06537 · Cited by 39
Unmet Needs and Evolving Treatment for Limb Girdle Muscular Dystrophies
Pozsgai, E. R., Griffin, D., Potter, R. A., Sahenk, Z., Lehman, K. J., Rodino‐Klapac, L. R., & Mendell, J. R. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0066 · Cited by 41
Zhang, T., Xie, Z., Zheng, X., Liang, Y., Lu, Y., Zhong, H., Qian, F., Zhu, Y., Sun, R., Sheng, Y., et al. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115856 · Cited by 39
Viral Detection: Past, Present, and Future
Κατσαρού, Κ., Bardani, E., Kallemi, P., & Kalantidis, K. (2019) · BioEssays · doi:10.1002/bies.201900049 · Cited by 40
Harnessing the type I CRISPR‐Cas systems for genome editing in prokaryotes
Xu, Z., Li, Y., Li, M., Xiang, H., & Yan, A. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15116 · Cited by 39
“1), class 2 CRISPR-Cas systems have been reprogramed extensively for genome editing and various genetic applications including RNA editing, diagnostics and biosensing in a broad range of organisms, especially eukaryotes (Charpentier and Marraffini, 2014; Knott and Doudna, 2018; Li et al., 2019).”
BackgroundCRISPR-Cas based molecular diagnostics for foodborne pathogens
Lu, Y., Yang, H., Bai, J., He, Q., & Deng, R. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2153792 · Cited by 41
“After recognition, Cas12a effector utilizes the nuclease site in the RuvC domain to cleave the target DNA, and generates 5 ′ -staggered ends rather than blunt ends (Knott and Doudna 2018; Wang, Zhang, and Li, 2020).”
BackgroundMethodEpiCas-DL : Predicting sgRNA activity for CRISPR-mediated epigenome editing by deep learning
Yang, Q., Wu, L., Meng, J., Ma, L., Zuo, E., & Sun, Y. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.034 · Cited by 40
“CRISPR-associated (Cas) nucleoproteins could achieve genomic specificity with the assistance of target-specific single-guide RNA (sgRNA) [1].”
BackgroundZhu, L., Liang, Z., Xu, Y., Chen, Z., Wang, J., & Zhou, L. (2023) · Biosensors · doi:10.3390/bios13060659 · Cited by 37
Verma, A. K., Tiwari, H., Singh, S., Gupta, P., Rai, N., Singh, S. K., Singh, B. P., Rao, S., & Gautam, V. (2023) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2023.2241486 · Cited by 37
“It has improved the accuracy of modifying genetic sequences in the scientific community (Knott and Doudna 2018).”
BackgroundCombination of nucleic acid amplification and CRISPR/Cas technology in pathogen detection
Zeng, D., Jiao, J., & Mo, T. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1355234 · Cited by 41
Brant, E. J., Eid, A., Kannan, B., Baloğlu, M. C., & Altpeter, F. (2024) · Plant Biotechnology Journal · doi:10.1111/pbi.14380 · Cited by 38
Engineering live cell surfaces with polyphenol-functionalized nanoarchitectures
He, Y., Liu, Q., He, Y., Deng, S., & Guo, J. (2025) · Chemical Science · doi:10.1039/d4sc07198k · Cited by 39
“8 Chemical synthesis techniques achieve stable covalent attachments between the reactive functional groups to the synthetic molecules or polymers on the cell surface.”
Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9
Cowan, P. J., Hawthorne, W. J., & Nottle, M. B. (2018) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000589 · Cited by 37
Clonal Reproduction through Seeds in Sight for Crops
Ozias‐Akins, P., & Conner, J. A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2019.12.006 · Cited by 37
CiBER-seq dissects genetic networks by quantitative CRISPRi profiling of expression phenotypes
Muller, R. Y., Meacham, Z. A., Ferguson, L., & Ingolia, N. T. (2020) · Science · doi:10.1126/science.abb9662 · Cited by 38
“C RISPR-Cas9 has emerged as a powerful and versatile tool for creating precise, programmable genetic perturbations (1).”
BackgroundMethodRecent Advances in CRISPR/Cas-Based Biosensors for Protein Detection
Wang, J., Yang, X., Wang, X., & Wang, W. (2022) · Bioengineering · doi:10.3390/bioengineering9100512 · Cited by 41
“However, most of the currently published reviews are about the research progress of CRISPR/Cas system applications in gene editing [39,40], gene therapy [41], bioimaging [42,43], pathogen diagnosis [44,45], and nucleic acid detection [46–48].”
BackgroundCRISPR-assisted transcription activation by phase-separation proteins
Liu, J., Chen, Y., Nong, B., Luo, X., Cui, K., Li, Z., Zhang, P., Tan, W., Yang, Y., Ma, W., et al. (2023) · Protein & Cell · doi:10.1093/procel/pwad013 · Cited by 38
“The class 2 type II effector Cas9 and type V effector Cas12 in particular have revolutionized both basic and clinical research in cultured cells and whole animals (Knott and Doudna, 2018; Uddin et al., 2020).”
BackgroundNayak, A., & Dutta, D. (2023) · Sustainable Food Technology · doi:10.1039/d3fb00059a · Cited by 43
Yu, J. H., Qu, S., Shi, G., Fan, L., Qian, J., Sun, Z., Lu, F., & Han, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c11334 · Cited by 39
Gao, Z. F., Zheng, L. L., Dong, L. M., Li, J. Z., Shen, Y., Chen, P., & Xia, F. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00848 · Cited by 36
Song, N., Chu, Y., Li, S., Fan, X., Tang, J., Li, H., Tao, R., Li, F., Li, J., Yang, D., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202306634 · Cited by 36
Liu, Z., Shan, H., Chen, S., Chen, M., Zhang, Q., Lai, L., & Li, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201900476rr · Cited by 37
Characterization of Cas proteins for CRISPR‐Cas editing in streptomycetes
Yeo, W. L., Heng, E., Tan, L. L., Lim, Y. W., Lim, Y. H., Hoon, S. S., Zhao, H., Zhang, M. M., & Wong, F. T. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27021 · Cited by 37
Genome-scale CRISPRi screening: A powerful tool in engineering microbiology
Sun, L., Zheng, P., Sun, J., Wendisch, V. F., & Wang, Y. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100089 · Cited by 36
RNAi and genome editing of sugarcane: Progress and prospects
Brant, E. J., Zuniga‐Soto, E., & Altpeter, F. (2025) · The Plant Journal · doi:10.1111/tpj.70048 · Cited by 37
“This approach provides enhanced target flexibility, simplified system design, and high multiplex targeting potential (Knott & Doudna, 2018; Stella et al., 2017).”
Advancements in CRISPR/Cas systems for disease treatment
Xu, Y., Le, H., Wu, Q., Wang, N., & Gong, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.007 · Cited by 35
“Over the last decade, it has transformed into a third-generation gene editing tool, profoundly influencing biomedical research 2,32,33 .”
Yang, L. C., Yang, B., & Chen, J. (2019) · Cell · doi:10.1016/j.cell.2019.11.030 · Cited by 38
An Overview of CRISPR-Based Technologies in Wine Yeasts to Improve Wine Flavor and Safety
Vilela, A. (2021) · Fermentation · doi:10.3390/fermentation7010005 · Cited by 38
“Cas9 is driven to its target locus by a small programmable RNA—an RNA sequence that can be engineered to a specific target [36].”
Background
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.